Hjem › Follikulært lymfom › California › Baldwin Park
Kliniske studier for Follikulært lymfom i Baldwin Park, CA
16 studier for Follikulært lymfom søker deltakere på steder i og rundt Baldwin Park (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
RekruttererFase 3
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi unna
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
RekruttererFase 2/3
- City of Hope - Duarte Cancer Center ( Site 1301), Duarte · 4 mi unna
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RekruttererFase 1
- City of Hope, Duarte · 4 mi unna
Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma
RekruttererFase 2
- City of Hope Medical Center, Duarte · 4 mi unna
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
RekruttererFase 1
- City of Hope, Duarte · 4 mi unna
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
RekruttererFase 2
- Research Site, Duarte · 4 mi unna
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
RekruttererFase 1
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi unna
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RekruttererFase 1/2
- City of Hope, Duarte · 4 mi unna
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
RekruttererFase 1
- City of Hope, Duarte · 4 mi unna
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RekruttererFase 1
- City of Hope, Duarte · 4 mi unna
Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
RekruttererFase 1
- City of Hope Medical Center, Duarte · 4 mi unna
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
RekruttererFase 3
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi unna
Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
RekruttererFase 1
- City of Hope Medical Center, Duarte · 4 mi unna
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
RekruttererFase 1/2
- City of Hope, Duarte · 4 mi unna
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
RekruttererFase 1
- City of Hope, Duarte · 4 mi unna
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Duarte · 4 mi unna
Follikulært lymfom-studier i andre byer
- New York City, NY24 studier
- Milwaukee, WI19 studier
- Nashville, TN18 studier
- Houston, TX18 studier
- Boston, MA17 studier
- Seattle, WA15 studier
- Durham, NC15 studier
- Salt Lake City, UT13 studier
- Columbus, OH13 studier
- Chicago, IL12 studier
- San Antonio, TX12 studier
- Philadelphia, PA12 studier
Andre studier i Baldwin Park
- Brystkreft44 studier
- Akut myelogen leukemi40 studier
- Kolorektal kreft37 studier
- Ikke-småcellet lungekreft36 studier
- Kreft (alle typer)34 studier
- Prostatakreft30 studier
- Metastatisk kreft30 studier
- Myelodysplastiske syndromer26 studier
- Eggstokkreft25 studier
- Lungekreft24 studier
- Multipelt myelom23 studier
- Mavekreft22 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.